203 related articles for article (PubMed ID: 32332749)
21. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.
Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307
[TBL] [Abstract][Full Text] [Related]
22. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
[TBL] [Abstract][Full Text] [Related]
23. Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening.
Moorwood C; Khurana TS
Expert Opin Drug Discov; 2013 May; 8(5):569-81. PubMed ID: 23473647
[TBL] [Abstract][Full Text] [Related]
24. 2-Arylbenzo[
Babbs A; Berg A; Chatzopoulou M; Davies KE; Davies SG; Edwards B; Elsey DJ; Emer E; Guiraud S; Harriman S; Lecci C; Moir L; Peters D; Robinson N; Rowley JA; Russell AJ; Squire SE; Tinsley JM; Wilson FX; Wynne GM
J Med Chem; 2020 Jul; 63(14):7880-7891. PubMed ID: 32551645
[TBL] [Abstract][Full Text] [Related]
25. sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19/miR-675/let-7 and miR-21 pathways.
Morgoulis D; Berenstein P; Cazacu S; Kazimirsky G; Dori A; Barnea ER; Brodie C
Cell Death Dis; 2019 Jan; 10(2):82. PubMed ID: 30692507
[TBL] [Abstract][Full Text] [Related]
26. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Chatzopoulou M; Conole D; Emer E; Rowley JA; Willis NJ; Squire SE; Gill B; Brough S; Wilson FX; Wynne GM; Davies SG; Davies KE; Russell AJ
Bioorg Med Chem; 2022 Sep; 69():116812. PubMed ID: 35772287
[TBL] [Abstract][Full Text] [Related]
28. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
29. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
[TBL] [Abstract][Full Text] [Related]
30. Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.
Pisani C; Strimpakos G; Gabanella F; Di Certo MG; Onori A; Severini C; Luvisetto S; Farioli-Vecchioli S; Carrozzo I; Esposito A; Canu T; Mattei E; Corbi N; Passananti C
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1172-1182. PubMed ID: 29408646
[TBL] [Abstract][Full Text] [Related]
31. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
32. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
[TBL] [Abstract][Full Text] [Related]
33. A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation.
Moorwood C; Soni N; Patel G; Wilton SD; Khurana TS
J Biomol Screen; 2013 Apr; 18(4):400-6. PubMed ID: 23112083
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
Albesa M; Ogrodnik J; Rougier JS; Abriel H
Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
[TBL] [Abstract][Full Text] [Related]
35. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
36. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
Miura P; Jasmin BJ
Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
[TBL] [Abstract][Full Text] [Related]
37. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
[TBL] [Abstract][Full Text] [Related]
38. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Lowe DA; Kostek MC
Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
[TBL] [Abstract][Full Text] [Related]
39. Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy.
Péladeau C; Jasmin BJ
RNA Biol; 2021 Sep; 18(9):1238-1251. PubMed ID: 33164678
[TBL] [Abstract][Full Text] [Related]
40. Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
Markham BE; Kernodle S; Nemzek J; Wilkinson JE; Sigler R
PLoS One; 2015; 10(8):e0134832. PubMed ID: 26248188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
